Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 751 to 760 of 2382
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Eptinezumab for preventing migraine
TA871
1 March 2023
1 March 2023
ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment
MIB39
30 September 2015
30 September 2015
Erectile dysfunction: Alprostadil cream
ESNM50
9 December 2014
9 December 2014
Erectile dysfunction: avanafil
ESNM45
12 August 2014
12 August 2014
Erenumab for preventing migraine
TA682
10 March 2021
10 March 2021
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen
TA515
28 March 2018
28 March 2018
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
TA423
21 December 2016
21 December 2016
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
TA374
16 December 2015
16 December 2015
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
TA258
27 June 2012
27 June 2012
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer
TA227
29 June 2011
29 June 2011
Previous page
1
…
74
75
Current page
76
77
78
…
239
Page
76
of
239
Next page
Results per page
10
25
50
All
Back to top